| Financial Year |
March 31 2023 |
| Monetary Funds |
205,070,966.14 |
| Held-for-trading Financial Assets |
10,669,539.46 |
| Notes Receivable |
-- |
| Accounts Receivable |
168,247,960.76 |
| Advances to Suppliers |
2,658,022.72 |
| Other Receivables |
23,890,896.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,672,847.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,070,927.77 |
| Total Current Assets |
420,281,160.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,484,304.54 |
| Investment Properties |
-- |
| Fixed Assetes |
19,668,947.07 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
350,450.98 |
| R&D expenses |
-- |
| Goodwill |
8,441,122.41 |
| Long-Term Deferred and Prepaid Expenses |
83,863,695.83 |
| Deferred Income Tax Assets |
294,805.64 |
| Other Non-Current Assets |
628,735.59 |
| Sub-Total of Non-Current Assets |
134,145,672.14 |
| Total Assets |
554,426,832.54 |
| Short-Term Loans |
61,084,485.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
82,245,399.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,244,897.19 |
| Taxes Payable |
5,739,775.21 |
| Interest Payable |
-- |
| Dividend Payable |
931,102.81 |
| Other payables |
161,550,634.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,743.16 |
| Other Current Liabilities |
11,491,030.16 |
| Sub-Total of Current Liabilities |
456,123,365.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
353,747.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,981,399.52 |
| Total Liabilities |
474,104,764.56 |
| Paid-In Capital(Or Share Stock) |
311,573,901.00 |
| Capital Surplus |
170,816,843.30 |
| Surplus Reserve |
34,545,734.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-505,141,319.97 |
| Minority Stockholder's Interest |
68,526,909.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,795,158.51 |
| Owner's Equity（Stockholder's Equity） |
80,322,067.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
554,426,832.54 |
